Genetic Technologies Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited with three other
pharmaceutical manufacturers in Australasia:
Rhythm Biosciences Ltd
(2020
sales of 46,266.00 Australian Dollars [US$35,976.44 ]
),
Prescient Therapeutics Ltd
(70,361.00 Australian Dollars [US$54,712.71 ]
of which 100%
was Clinical stage oncology), and
Alterity Therapeutics Ltd
(17,117.00 Australian Dollars [US$13,310.18 ]
of which 100%
was Reaserch and development in the field of).
Sales Analysis.
Genetic Technologies Limited reported sales of A$9,864.00 (US$7.67 thousand)
for the
fiscal
year ending
June of 2020.
This
represents
a
sharp
decrease of 61.2%
versus 2019, when the company's sales were A$25,444.00 .